Acorda therapeutics, inc. (ACOR)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Revenues:
Milestone revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Gross product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Less: discounts and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Total net revenues

176,370

192,408

211,064

306,156

409,405

471,433

590,679

588,930

575,066

588,287

540,515

535,063

523,083

519,601

509,878

522,464

508,713

492,660

479,629

437,391

420,813

401,480

376,201

355,159

345,083

336,430

325,310

317,828

306,431

305,814

296,985

312,579

302,199

292,237

286,394

256,985

234,544

191,005

139,418

88,345

0

0

0

Costs and expenses:
Cost of sales

29,893

34,849

47,658

64,824

85,805

97,640

102,646

107,486

106,773

111,322

115,050

112,702

109,472

107,475

103,667

100,764

97,037

92,297

90,873

86,707

82,898

79,981

73,380

70,018

68,054

66,009

63,838

61,386

58,027

57,007

54,235

66,125

64,597

64,183

63,693

48,708

44,492

35,518

25,176

16,461

0

0

0

Cost of milestone and license revenue

-

-

-

-

-

-

-

-

-

634

634

634

634

634

634

634

634

634

634

634

634

634

634

634

634

634

635

635

634

634

634

2,383

2,384

2,384

2,391

0

0

-

0

-

-

-

-

Research and development

51,760

60,083

78,118

84,900

91,851

106,383

114,467

124,898

150,172

166,105

184,760

206,251

205,360

203,437

193,628

182,207

163,143

149,209

131,143

104,365

89,584

73,470

61,850

59,111

55,879

53,877

57,766

55,958

55,376

53,881

45,994

43,051

42,425

42,108

39,776

38,658

33,246

30,600

30,825

30,723

0

0

0

Selling, general and administrative

181,229

192,846

188,441

183,310

177,378

172,254

174,955

172,125

177,196

181,619

201,147

215,211

228,481

235,437

229,375

225,626

215,841

205,630

209,101

205,865

203,690

201,813

192,364

186,880

184,239

185,545

184,131

181,916

178,143

168,690

158,817

153,414

149,325

148,508

154,060

149,900

143,871

132,657

114,799

108,166

0

0

0

Goodwill impairment

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

30,763

25,636

17,946

10,493

3,518

1,670

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of acquired contingent consideration

-98,017

-86,935

-23,242

50,400

56,200

55,000

46,000

22,900

36,300

40,900

13,500

17,600

13,200

8,600

15,400

14,900

14,000

10,900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

450,792

504,040

586,482

393,927

414,752

432,947

720,971

749,678

792,153

821,101

554,537

552,398

557,147

555,583

542,704

524,131

490,655

458,670

448,342

410,962

389,097

365,089

328,228

316,643

308,806

306,065

306,370

299,895

292,180

280,212

259,680

264,973

258,731

257,183

260,250

238,244

222,428

199,435

170,965

155,351

0

0

0

Operating loss

-274,422

-311,632

-375,418

-87,771

-5,347

38,486

-130,292

-160,748

-217,087

-232,814

-14,022

-17,335

-34,064

-35,982

-32,826

-1,667

18,058

33,990

31,287

26,429

31,716

36,391

47,973

38,516

36,277

30,365

18,940

17,933

14,251

25,602

37,305

47,606

43,468

35,054

26,144

18,741

12,116

-8,430

-31,547

-67,005

0

0

0

Other (expense) income, net:
Interest and amortization of debt discount expense

23,014

21,872

21,573

22,488

22,524

21,597

21,207

19,972

20,018

18,664

18,150

18,374

16,947

16,527

15,534

15,167

15,144

15,472

16,271

16,831

13,247

9,288

5,401

1,348

1,671

2,170

2,269

2,098

1,705

1,880

1,706

2,280

3,200

3,570

3,929

3,926

3,844

3,922

4,056

4,619

0

0

0

Interest income

2,986

4,170

4,433

5,276

4,688

3,518

2,445

1,299

424

136

133

149

162

339

469

543

589

440

360

497

568

674

761

666

667

668

666

639

596

552

532

531

541

552

532

509

511

575

764

1,020

0

0

0

Other expenses

0

-

-

-

-

-

-

0

-

-

-

-

-

9,902

10,024

9,956

10,732

411

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

Realized loss on foreign currency transactions

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Total other expense, net

35,024

37,384

-17,157

-17,229

-17,828

-18,063

-18,831

-18,759

-19,698

-19,071

-16,925

-17,294

-17,769

-6,286

-6,715

-6,154

-3,823

-14,621

-15,266

-15,630

-12,326

-8,382

-4,640

-682

-1,004

-1,502

-1,609

-1,465

-1,115

-1,334

-1,192

-1,767

-2,677

-3,036

-3,397

-3,409

-3,325

-3,339

-3,323

-3,632

0

0

0

Loss before taxes

-239,398

-274,248

-392,575

-105,000

-23,175

20,423

-149,123

-179,507

-236,785

-251,885

-30,947

-34,629

-51,833

-42,268

-39,541

-7,821

14,235

19,369

16,021

10,799

19,390

28,009

43,333

37,834

35,273

28,863

17,331

16,468

13,136

24,268

36,113

45,839

40,791

32,018

22,747

15,332

8,791

-11,769

0

0

0

-

-

Benefit from income taxes

-7,582

-1,282

-63,616

-25,636

-17,436

-13,259

-2,070

-21,202

-24,131

-28,526

24,442

8,597

2,154

-6,665

-16,237

-1,490

612

8,311

13,837

603

5,506

10,337

19,799

18,776

16,990

12,422

-125,890

-128,870

-132,837

-130,690

1,433

1,886

1,668

1,413

0

0

0

-

0

0

0

-

-

Net loss

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) attributable to non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-231,833

-272,966

-352,537

-42,805

0

-

0

0

-

-223,359

-55,389

-42,919

-53,002

-34,618

-22,319

-5,653

13,623

11,058

2,184

10,196

13,884

17,672

23,534

19,058

18,283

16,441

143,221

145,338

145,973

154,958

34,680

43,953

39,123

30,605

21,582

15,153

8,674

-11,769

-34,870

-70,637

0

0

0

Net loss per sharebasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-0.41

-

-0.28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.62

Weighted average common shares outstanding used in computing net loss per sharebasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

45,808

-

45,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,708

Net loss per share—basic

-0.14

1.38

-5.55

-0.58

-1.00

0.20

-0.29

0.99

-0.18

-

-0.55

-0.18

-

-

-

-0.40

-0.01

0.22

0.09

0.02

-0.07

0.01

0.29

0.11

0.02

0.15

0.19

0.10

-0.03

3.37

0.24

0.12

0.20

0.33

0.48

-0.01

-0.02

0.11

0.32

-0.18

-0.56

-0.51

-

Net loss per share—diluted

-0.14

1.38

-5.55

-0.58

-1.00

0.20

-0.29

0.98

-0.18

-

-0.55

-0.18

-

-

-

-0.40

-0.01

0.21

0.09

0.02

-0.07

0.01

0.28

0.11

0.02

0.15

0.18

0.09

-0.03

3.30

0.24

0.11

0.19

0.32

0.47

-0.01

-0.02

0.12

0.31

-0.18

-0.56

-0.51

-

Weighted average common shares outstanding used in computing net loss per share—basic

47,703

47,579

47,511

47,486

47,472

47,528

47,184

46,799

46,529

-

46,002

45,943

-

-

-

45,338

44,815

42,630

42,174

42,085

42,031

41,540

41,094

41,032

40,934

40,725

40,315

39,960

39,832

39,600

39,463

39,433

39,340

39,182

39,100

38,937

38,781

115,322

38

38

38,021

37,749

-

Weighted average common shares outstanding used in computing net loss per share—diluted

47,703

47,579

47,511

47,486

47,472

48,450

47,184

47,201

46,529

-

46,002

45,943

-

-

-

45,338

44,815

45,739

43,432

43,282

42,031

43,144

42,365

42,432

42,235

43,317

41,996

41,583

39,832

40,663

40,159

40,099

40,407

42,364

40,174

38,937

38,781

115,320

39

38

38,021

37,749

-

Net Product Revenues
Total net revenues

164,074

180,736

199,676

294,849

398,070

459,739

563,431

557,815

540,159

549,749

513,713

507,864

495,803

493,358

483,067

495,889

482,759

466,111

453,024

410,175

392,329

373,292

349,011

330,290

320,696

310,317

299,359

291,805

280,792

282,381

276,039

269,253

263,019

256,271

251,635

247,480

225,080

181,545

129,990

81,274

0

0

0

Royalty Revenues
Total net revenues

12,296

11,672

11,388

11,307

11,335

11,694

24,984

26,587

28,115

29,481

17,744

18,141

18,222

17,186

17,754

17,518

16,897

17,492

17,548

18,159

19,427

19,131

17,048

0

0

-

0

-

-

-

11,889

9,269

5,123

1,909

577

0

0

-

0

-

-

-

-

License Revenue
Total net revenues

-

-

-

-

-

-

-

-

-

9,057

9,058

9,058

9,058

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,056

9,056

9,056

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,057

9,150

9,243

9,336

9,428

9,428

7,071

0

0

0